353
Views
4
CrossRef citations to date
0
Altmetric
Review

Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease

, &
Pages 349-355 | Published online: 09 Feb 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lisa M Nijm, Justin Schweitzer & Jennifer Gould Blackmore. (2023) Glaucoma and Dry Eye Disease: Opportunity to Assess and Treat. Clinical Ophthalmology 17, pages 3063-3076.
Read now
Siddharth Bhargava, Ranjani Panda, Asma M Azam & John D Sheppard. (2023) A review of dry eye disease therapies: exploring the qualities of varenicline solution nasal spray. Expert Review of Ophthalmology 18:1, pages 1-10.
Read now

Articles from other publishers (2)

Burcu Uner, Samet Ozdemir, Cetin Tas, Melike Uner & Yildiz Ozsoy. (2023) Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity. AAPS PharmSciTech 24:4.
Crossref
Jill SturdivantStuart S. WilliamsMaria InaMeredith WekslerAlan McDougalDaphne ClancyMitchell A. deLongNatalie GirouardMaria ZaretskaiaKaren BrennanAngela GlendenningBriana FoleyCheng-Wen LinJeffrey C. WhiteCasey KopczynskiCurtis R. Kelly. (2023) Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid Conjugates. Journal of Ocular Pharmacology and Therapeutics 39:2, pages 117-127.
Crossref